Shanghai Zhigen Pharmaceutical Technology Co., Ltd.

(1) To study the tolerability and pharmacokinetics of healthy subjects after single oral administration of different doses of ZG-002 tablets; (2) To study the tolerability and pharmacokinetics of healthy subjects after multiple oral administration of different doses of ZG-002 tablets; (3) To study the effect of diet on the pharmacokinetics of oral ZG-002 tablets in healthy subjects.

To study the tolerance and pharmacokinetics of a single oral administration of different doses of ZG-001 capsules in healthy subjects, to study the tolerance and pharmacokinetics of multiple oral administration of different doses of ZG-001 capsules in healthy subjects, and to study the effect of diet on the pharmacokinetics of oral ZG-001 capsules in healthy subjects, so as to provide a basis for later clinical trials.